Connect Biopharma Holdings revenue was $1.97M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $48.0k, up Infinity% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNTB annual revenue was $26.0M, with Infinity% growth year-over-year.
CNTB past revenue growth
How has CNTB's revenue growth performed historically?
Connect Biopharma Holdings (NASDAQ: CNTB) reported Q2 2025 revenue of $48.00 thousand up 99.8% year over year. In the same quarter last year, Connect Biopharma Holdings's revenue was $24.12 million.
What was Connect Biopharma Holdings's revenue in 2024?
Connect Biopharma Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $26.03 million, a Infinity% increase year over year.
How much does Connect Biopharma Holdings make in a day?
Based on Connect Biopharma Holdings annual revenue for the past five years, CNTB makes an average of $14,264.66 per day.
What was Connect Biopharma Holdings's annual revenue growth in the past year?
As of Q3 2025, Connect Biopharma Holdings's revenue has grown -91.85% year over year. This is 238.53 percentage points lower than the US Biotechnology industry revenue growth rate of 146.68%. Connect Biopharma Holdings's revenue in the past year totaled $1.97 million.
How much does Connect Biopharma Holdings make in a year?
Connect Biopharma Holdings's revenue by year for the past five years is:
Connect Biopharma Holdings's revenue for the twelve months ending Dec 31, 2024 was $26.03 million, a Infinity% increase year over year.
Connect Biopharma Holdings's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Connect Biopharma Holdings's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Connect Biopharma Holdings's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Connect Biopharma Holdings's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.